---
author: Harvey Guo
created: <% tp.file.creation_date() %>
modified: <% tp.file.last_modified_date() %>
aliases: <% tp.file.title %>
description:
tags:
share: true
---

# Pathophysiology
- Formation of procoagulatory antiphospholipid antibodies 
	- Antibodies form complexes with anticoagulant proteins, thereby inactivating them (e.g., protein C, protein S, antithrombin III).
	- Antibodies activate platelets and vascular endothelium. 
- Induction of a hypercoagulable state → ↑ risk of thrombosis and embolism [3]
# Clinical features
APS usually manifests with recurring thrombotic events that may affect any organ.
Pregnancy-related: recurrent miscarriages and premature births.(Caused by thrombosis of [placental](https://next.amboss.com/us/article/Do01VS#Z414c23d8bf8265247dd2e1e7e9b0d89c) vessels and possible subsequent [placental](https://next.amboss.com/us/article/Do01VS#Z414c23d8bf8265247dd2e1e7e9b0d89c) [infarction](https://next.amboss.com/us/article/VP0GdT#Zb11fb76135fecdea9dd3e778dbe469e3))
> <mark style="background: #BBFABBA6;">Thrombosis in APS is typically unprovoked (e.g., [unprovoked DVT](https://next.amboss.com/us/article/fh0kWf#Z15a08304a073ea63bd825729a0b8e82f)), recurrent, and/or manifests in unusual sites (e.g., [kidneys](https://next.amboss.com/us/article/m60VlS#Z517d2cc21845787cbf2c6ff27c21cd8e), [liver](https://next.amboss.com/us/article/j60_kS#Zd0ed3eb208321943f24b364e0a464294), [retina](https://next.amboss.com/us/article/cp0aoS#Zafbc538c70facdb76c5c65393ad05dbb)). It is most commonly seen in younger individuals (< 50 years of age) and in individuals with comorbid autoimmune diseases (e.g., [SLE](https://next.amboss.com/us/article/dT0op2#Zc038efa4f85b330e4a8d1d0224d5f1a9)).</mark>

# Diagnose
Antiphospholipid antibodies ([aPL antibodies](https://next.amboss.com/us/article/hR0c5f#Zc64f6e326ddf58b2bc9a198ed8f87dd2))
- Lupus anticoagulant (LA): [antibodies](https://next.amboss.com/us/article/x50Emg#Zcafc1c81671c54115ab5d77c08d696a0) against certain phospholipids in [cellular membranes](https://next.amboss.com/us/article/Lo0wcS#Z4224d324188134290d99f44a379e40f9)
- <mark style="background: #FFF3A34A;">Anticardiolipin antibodies</mark> ([IgG](https://next.amboss.com/us/article/x50Emg#Zdcbaf6f4b43f0363afdf3d6aaacd924c) and [IgM](https://next.amboss.com/us/article/x50Emg#Ze9de183a682c9f06a4bdba89dd15ca26))
- Anti-β2-glycoprotein antibodies ([IgG](https://next.amboss.com/us/article/x50Emg#Zdcbaf6f4b43f0363afdf3d6aaacd924c) and [IgM](https://next.amboss.com/us/article/x50Emg#Ze9de183a682c9f06a4bdba89dd15ca26))